California AB1682 mandates coverage for scalp cooling to reduce chemotherapy-induced hair loss in large group health plans and Medi-Cal managed care.

California AB1682 adds provisions to the Welfare and Institutions Code, Insurance Code, and Health and Safety Code, requiring coverage for scalp cooling in large group health plans and Medi-Cal managed care plans. Scalp cooling, defined as the use of FDA-cleared medical devices applied to the scalp during chemotherapy, aims to reduce hair loss. This coverage may include copayments, coinsurance, or deductibles, but these must be no less favorable than those for oncology supportive care services. The act excludes non-FDA-cleared cold caps and similar products.

California AB1682 mandates coverage for scalp cooling to reduce chemotherapy-induced hair loss in large group health plans and Medi-Cal managed care.

California AB1682 adds provisions to the Welfare and Institutions Code, Insurance Code, and Health and Safety Code, requiring coverage for scalp cooling in large group health plans and Medi-Cal managed care plans. Scalp cooling, defined as the use of FDA-cleared medical devices applied to the scalp during chemotherapy, aims to reduce hair loss. This coverage may include copayments, coinsurance, or deductibles, but these must be no less favorable than those for oncology supportive care services. The act excludes non-FDA-cleared cold caps and similar products.